Cargando…

Upregulation of CD109 Promotes the Epithelial-to-Mesenchymal Transition and Stemness Properties of Lung Adenocarcinomas via Activation of the Hippo-YAP Signaling

Metastasis is the leading cause of death in lung adenocarcinomas. Identifying potential prognostic biomarkers and exploiting regulatory mechanisms could improve the diagnosis and treatment of lung cancer patients. We previously found that cluster of differentiation 109 (CD109) was upregulated in lun...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Kang-Yun, Kuo, Tai-Chih, Chou, Chih-Ming, Hsu, Wen-Jing, Lee, Wei-Cheng, Dai, Jia-Zih, Wu, Sheng-Ming, Lin, Cheng-Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823273/ https://www.ncbi.nlm.nih.gov/pubmed/33375719 http://dx.doi.org/10.3390/cells10010028

Ejemplares similares

WWC3 inhibits epithelial–mesenchymal transition of lung cancer by activating Hippo-YAP signaling
por: Han, Qiang, et al.
Publicado: (2018)

The Crosstalk between Src and Hippo/YAP Signaling Pathways in Non-Small Cell Lung Cancer (NSCLC)
por: Hsu, Ping-Chih, et al.
Publicado: (2020)

SOX9 promotes epithelial-mesenchymal transition via the Hippo-YAP signaling pathway in gastric carcinoma cells
por: Zhou, Hailang, et al.
Publicado: (2019)

Notch3 inhibits epithelial–mesenchymal transition by activating Kibra-mediated Hippo/YAP signaling in breast cancer epithelial cells
por: Zhang, X, et al.
Publicado: (2016)

GABAB receptor inhibits tumor progression and epithelial-mesenchymal transition via the regulation of Hippo/YAP1 pathway in colorectal cancer
por: Wang, Huihui, et al.
Publicado: (2021)

YAP and the Hippo pathway in cholangiocarcinoma
por: Sugihara, Takaaki, et al.
Publicado: (2019)

Hippo transducer TAZ promotes epithelial mesenchymal transition and supports pancreatic cancer progression
por: Xie, Dacheng, et al.
Publicado: (2015)

Platycodin D confers oxaliplatin Resistance in Colorectal Cancer by activating the LATS2/YAP1 axis of the hippo signaling pathway
por: Wang, Chien-Hao, et al.
Publicado: (2023)

Elevation of CD109 promotes metastasis and drug resistance in lung cancer via activation of EGFR‐AKT‐mTOR signaling
por: Lee, Kang‐Yun, et al.
Publicado: (2020)

Targeting Hippo coactivator YAP1 through BET bromodomain inhibition in esophageal adenocarcinoma
por: Song, Shumei, et al.
Publicado: (2020)

Clinical potential of the Hippo-YAP pathway in bladder cancer
por: Cheng, Xin, et al.
Publicado: (2022)

Hippo-YAP/TAZ signaling in angiogenesis
por: Park, Jeong Ae, et al.
Publicado: (2018)

The Hippo Pathway Effector YAP1 Regulates Intestinal Epithelial Cell Differentiation
por: Fallah, Sepideh, et al.
Publicado: (2020)

Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms
por: Dobrokhotov, Oleg, et al.
Publicado: (2018)

Expression of YAP in endometrial carcinoma tissues and its effect on epithelial to mesenchymal transition
por: Cheng, Yun, et al.
Publicado: (2020)

Hippo/YAP signaling pathway is involved in osteosarcoma chemoresistance
por: Wang, Dong-Yu, et al.
Publicado: (2016)

Physical Interaction between HPV16E7 and the Actin-Binding Protein Gelsolin Regulates Epithelial-Mesenchymal Transition via HIPPO-YAP Axis
por: Matarrese, Paola, et al.
Publicado: (2021)

MicroRNAs Regulating Hippo-YAP Signaling in Liver Cancer
por: Lee, Na-Hyun, et al.
Publicado: (2021)

The Multiple Interactions of RUNX with the Hippo–YAP Pathway
por: Chuang, Linda Shyue Huey, et al.
Publicado: (2021)

Hippo-Yap/Taz signalling in zebrafish regeneration
por: Riley, Susanna E., et al.
Publicado: (2022)

Induction of reprogramming of human amniotic epithelial cells into iPS cells by overexpression of Yap, Oct4, and Sox2 through the activation of the Hippo-Yap pathway
por: Zhao, Yanhui, et al.
Publicado: (2017)

Pin1/YAP pathway mediates matrix stiffness‐induced epithelial–mesenchymal transition driving cervical cancer metastasis via a non‐Hippo mechanism
por: Yang, Long, et al.
Publicado: (2022)

Angiomotin regulates prostate cancer cell proliferation by signaling through the Hippo-YAP pathway
por: Zeng, Hao, et al.
Publicado: (2016)

LncRNA modulates Hippo-YAP signaling to reprogram iron metabolism
por: He, Xin-yu, et al.
Publicado: (2023)

ELK1 Promotes Epithelial-Mesenchymal Transition and the Progression of Lung Adenocarcinoma by Upregulating B7-H3
por: Yu, Ting-ting, et al.
Publicado: (2021)

Upregulation of long noncoding RNA CCAT1-L promotes epithelial–mesenchymal transition in gastric adenocarcinoma
por: Fang, Hua, et al.
Publicado: (2018)

Regorafenib inhibits epithelial-mesenchymal transition and suppresses cholangiocarcinoma metastasis via YAP1-AREG axis
por: Chang, Yu-Chan, et al.
Publicado: (2022)

Disruption of Cancer Metabolic SREBP1/miR-142-5p Suppresses Epithelial–Mesenchymal Transition and Stemness in Esophageal Carcinoma
por: Huang, Chih-Ming, et al.
Publicado: (2019)

Syndecan-2 modulates the YAP pathway in epithelial-to-mesenchymal transition-related migration, invasion, and drug resistance in colorectal cancer
por: Yang, Yang, et al.
Publicado: (2023)

Hippo Pathway-independent Restriction of TAZ and YAP by Angiomotin
por: Chan, Siew Wee, et al.
Publicado: (2011)

An emerging role for Hippo-YAP signaling in cardiovascular development
por: Zhou, Jiliang
Publicado: (2014)

Role of Hippo Pathway-YAP/TAZ Signaling in Angiogenesis
por: Boopathy, Gandhi T. K., et al.
Publicado: (2019)

The Crosstalk Between Hippo-YAP Pathway and Innate Immunity
por: Wang, Shuai, et al.
Publicado: (2020)

Control of skeletal morphogenesis by the Hippo-YAP/TAZ pathway
por: Vanyai, Hannah K., et al.
Publicado: (2020)

The role of Hippo‐YAP signaling in squamous cell carcinomas
por: Maehama, Tomohiko, et al.
Publicado: (2020)

Hippo-Yap Pathway Orchestrates Neural Crest Ontogenesis
por: Zhao, Xiaolei, et al.
Publicado: (2021)

New Insights into Hippo/YAP Signaling in Fibrotic Diseases
por: Mia, Masum M., et al.
Publicado: (2022)

Emerging Role of YAP and the Hippo Pathway in Prostate Cancer
por: Koinis, Filippos, et al.
Publicado: (2022)

The Hippo/YAP signaling pathway: the driver of cancer metastasis
por: Zhou, Tianxing, et al.
Publicado: (2023)

CD109 expression is upregulated in penile squamous cell carcinoma
por: Dong, Fengyun, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8ba5krh1if9pa0n0fg4t8j7o36